The S&P 500 snapped a five-month winning streak in August as a rise in U.S. Treasury yields weighed on shares of heavyweight growth stocks such as Apple and Microsoft , whose future cash flows are discounted more with a rise in rates.
J&J unveiled the first outlook for its standalone drugs and medical device businesses late last month after completing the spinoff of its consumer health company Kenvue.
Hemos resumido esta noticia para que puedas leerla rápidamente. Si estás interesado en la noticia, puedes leer el texto completo aquí. Leer más: